Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

CYTOPATH BIOPSY LAB INC;760 WESTCHESTER AVE;RYE BROOK;NY;10573

UEI: SLED_E658CB876D133D72

CYTOPATH BIOPSY LAB INC;760 WESTCHESTER AVE;RYE BROOK;NY;10573 is a federal contractor, registered under UEI SLED_E658CB876D133D72. It has been awarded $266,480 across 2 federal contracts. Primary work spans Medical Laboratories.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_E658CB876D133D72

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

$266.5K100%

Awards by NAICS

621511 - Medical Laboratories$266.5K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in CYTOPATH BIOPSY LAB INC;760 WESTCHESTER AVE;RYE BROOK;NY;10573's top NAICS codes and agencies

Reasonable Suspicion and Post-Accident TestingNueces County is seeking a subcontractor to provide urgent drug and alcohol testing services for reasonable suspicion and post-accident situations, with a requirement for round-the-clock availability and rapid result turnaround. The contract supports safety-critical operations by ensuring timely and reliable testing in high-stakes scenarios, where delays could impact compliance, investigations, or public safety. Responses are due by August 27, 2026, and the work falls under NAICS code 621511, indicating laboratory services related to medical diagnostics. The solicitation is open to qualified vendors capable of meeting strict time-sensitive demands, with no set-aside provisions specified. Performance is expected to be coordinated within Texas, though precise location details are not provided, and interested parties must submit proposals through the published public procurement portal.

POSTED

DEADLINE

Random Drug and Alcohol Testing Program ManagementNueces County seeks a contractor to manage a comprehensive random drug and alcohol testing program for approximately 750 employees, encompassing the full lifecycle of the testing process including random selection, scheduling, specimen collection, laboratory analysis, and ongoing compliance reporting. The contract requires consistent adherence to regulatory standards and accurate documentation to ensure program integrity and legal compliance. The solicitation is issued as a subcontract with a NAICS code of 621511, indicating a focus on medical and diagnostic laboratories, and the response deadline is set for August 27, 2026. Although specific location details for performance or contact information are not provided, the contracting entity is Nueces County in Texas, and interested parties must submit proposals through the designated public procurement portal before the stated deadline.

POSTED

DEADLINE

Pre-Employment Drug Testing ServicesNueces County is seeking a subcontractor to provide comprehensive pre-employment drug testing services for safety-sensitive employees, fully compliant with U.S. Department of Transportation regulations. The scope includes specimen collection, laboratory analysis, and Medical Review Officer review to ensure accurate, legally defensible results. All services must adhere strictly to federal DOT standards for testing procedures, chain of custody, and reporting protocols. The contract is solicited as a subcontract under NAICS code 621511, and responses are due by August 27, 2026. The services will be performed in Texas, though the exact location for performance is not specified. This procurement is open to qualified vendors capable of delivering timely, secure, and regulatory-compliant drug testing solutions to support workforce safety in safety-sensitive positions.

POSTED

DEADLINE

Histopathology and Laboratory Analysis ServicesThe contract seeks specialized histopathological evaluation services for kidney tissues derived from efficacy studies, requiring comprehensive laboratory analysis that includes tissue staining, detailed injury scoring, and digital pathology reporting to ensure accurate and reproducible results. The work demands expertise in interpreting morphological changes in renal tissues and delivering standardized, high-quality digital reports that support regulatory and research objectives. This is a subcontract solicited by the National Institutes of Health under the Department of Health and Human Services, classified under NAICS code 621511 for medical and diagnostic laboratories. The solicitation was posted on August 4, 2026, with a response deadline of August 19, 2026, and no set-aside provisions are specified. Performance location and point of contact details are not provided, and the full terms and requirements must be accessed through the official SAM.gov portal linked in the posting.

National Institutes Of Health Olao

POSTED

DEADLINE

Thyroid Molecular Testing Laboratory Services

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

PR Needed NEW Request / Thyroid Molecular Tests - THYROSEQ 5 year contract

Solicitation # 36C26026Q0888

The Department of Veterans Affairs through the 260-NETWORK Contract Office 20 is seeking proposals for a five-year contract to provide molecular testing services for thyroid nodule fine needle aspiration specimens using the THYROSEQ platform. This service supports the clinical assessment of indeterminate thyroid nodules by detecting genetic alterations linked to thyroid malignancy, thereby improving diagnostic accuracy and guiding patient management. The solicitation, numbered 36C26026Q0888, was posted on August 4, 2026, with responses due by August 24, 2026, and is not subject to any small business set-asides under NAICS code 621511 for medical laboratories. The contract will be managed from the office located in Vancouver, Washington, with performance expected primarily in Seattle, Washington. Primary point of contact is Hector D. Baltazar, Contracting Specialist, reachable at hector.baltazar@va.gov, with James Harris as the secondary contact for additional inquiries.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

Supplying and Delivering Two (2) Mobile Laboratory Setups to the US Embassy Kampala, Uganda

Solicitation # 19GE5026Q0129

The U.S. Department of State’s Regional Procurement Support Office in Frankfurt plans to award a sole source firm fixed price contract to DST innovation GmbH of Germany for the supply and delivery of two mobile laboratory setups to the U.S. Embassy in Kampala, Uganda. These labs are designed to enable rapid response to biological threats and disease outbreaks and are based on the proven mobile laboratory system developed by the Bundeswehr Institute of Microbiology in Munich. The setup includes an air-transportable inflatable tent, mobile gloveboxes, sample collection and processing equipment, PCR and ELISA instrumentation, light microscopy tools, personal protective equipment including PAPRs, solar power units, refrigeration and freezing units, an autoclave, water purification systems, ruggedized transportation cases, and a full complement of consumables and IT equipment. DST innovation is the only entity capable of providing this exact configuration due to its direct technical lineage from the Bundeswehr Institute and its proven deployment in regional countries such as Tanzania, Burundi, and Zambia. The decision to proceed on a sole source basis is grounded in the necessity for interoperability with existing regional diagnostic systems, standardized reagents used by the Ugandan Ministry of Health, and established operational protocols that ensure safe and effective outbreak response. Utilizing identical equipment already in use across neighboring countries minimizes logistical challenges, enhances data comparability, supports joint exercises, and reduces response times during critical public health emergencies. Any deviation from this specific configuration could compromise mission success and safety. The government is soliciting capability statements from other potential sources solely to confirm there are no other capable providers, with submissions due by August 15, 2026, at 11:59 pm Central European Summer Time via email to walkerak@state.gov. The contract award will proceed as sole source unless compelling evidence is presented demonstrating that another supplier can meet all specifications identically and reliably.

Acquisitions - Rpso Frankfurt

POSTED

DEADLINE

Q301--Cytopathology and Next Generation Sequencing Testing

Solicitation # 36C24226Q0875

The Department of Veterans Affairs Network Contracting Office 2 is soliciting offers to establish an Indefinite Delivery Indefinite Quantity (IDIQ) contract for comprehensive molecular diagnostic testing using next-generation sequencing to evaluate thyroid nodules with indeterminate fine-needle aspiration cytology. The goal is to improve clinical decision-making by providing scientifically validated genomic insights that enhance diagnostic accuracy, reduce the incidence of unnecessary surgical interventions, and enable timely, personalized care for Veterans at risk. This contract will support the delivery of clinically integrated testing services that align with evolving standards in cytopathology and molecular diagnostics. The solicitation, numbered 36C24226Q0875, was posted on August 4, 2026, with proposals due by August 21, 2026, and is classified under NAICS code 621511 for medical and diagnostic laboratories. Offerors must be prepared to perform services primarily at the Northport, New York location, with the contracting office located in Albany, New York. The primary point of contact is Contracting Officer Mariangie Rivera, reachable via email at Mariangie.Rivera@va.gov. This procurement is structured as a combined solicitation and does not specify a small business set-aside, indicating open competition across eligible industry participants seeking to provide advanced molecular testing solutions to the Veterans Health Administration.

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Diagnostic and Laboratory Support ServicesThe contract titled Diagnostic and Laboratory Support Services is a subcontract issued by the Community Health Center in California for the provision of comprehensive lab testing and diagnostic imaging services to support clinical operations. It encompasses a range of essential medical services including Pap smears, STI screening, glucose tolerance tests, blood work, and ultrasounds, all to be delivered in close coordination with on-site clinical staff to ensure seamless patient care. The services are specifically scheduled to be performed at the place of performance in San Bernardino, CA, with a zip code of 92408, and are governed under the NAICS code 621511, which classifies the work within the laboratory services sector. The contract has a posted date of August 3, 2026, with a firm response deadline of October 23, 2026, at 11:00 PM Pacific Time, indicating the window for interested parties to submit proposals. It does not specify any set-aside provisions or organization type requirements and is currently unassigned a solicitation number. No point of contact information is provided within the data, and the agency’s office address lacks detailed locality information, though the performance location is clearly designated. Interested bidders must ensure alignment with the technical and operational expectations tied to delivering timely, accurate diagnostic and laboratory services within an integrated clinical environment.

Community Health Center

POSTED

DEADLINE

PINE RIDGE IHS LAB-ISTAT REAGENT SUPPLIES

Solicitation # 75H70626Q00212

This contract is a combined synopsis and solicitation for commercial goods issued under FAR Subpart 12.6 by the Great Plains Area Indian Health Service, seeking a firm-fixed-price award for the supply of I-STAT reagents to the Pine Ridge Indian Health Service Hospital Laboratory in South Dakota. The solicitation, numbered 75H70626Q00212, is set aside 100% for Indian Small Business Economic Enterprise (ISBEE) with a NAICS code of 621511 and a size standard of 200 employees, requiring offerors to self-certify as Indian-owned firms. The total contract value is $32,727.00 for a one-year period from the date of award, with deliveries scheduled to begin on September 15, 2026, and conclude on September 14, 2027. Products must include Abbott-certified reagents, calibrators, and controls such as TRICONTROL levels 1–3, TROPONIN cartridges, and other specific items, with shipments required to include only new, unrefurbished items and no gray market or counterfeit parts. All offerings must comply with strict cold-chain standards, zero temperature excursions, and longest available expiration dating, with single-lot deliveries and precise labeling required for acceptance at the delivery site. Quotes must be submitted via email to Patricia Thompson by 12:00 PM MST on August 13, 2026, on company letterhead with signed and dated documentation including completed SF18 and IEE Representation forms, a technical description of goods, warranty terms, itemized pricing, remittance details, past performance references, and all mandatory representations and certifications per FAR 52.212-3 and SAM.gov registration requirements. Evaluation will follow the Lowest Price Technically Acceptable (LPTA) method, with technical acceptability in three critical areas: continuous supply capability (95% on-time delivery, 98% product acceptance, 100% shelf-life compliance, no cold-chain breaches), demonstrable past performance (rated acceptable/unacceptable with a single unacceptable disqualifying the offer), and the lowest evaluated price. Compliance with the Invoice Processing Platform (IPP) is mandatory for post-award invoicing under HHSAR 352.232-71, and offerors must have a valid UEI and be registered in SAM

Great Plains Area Indian Health Svc

POSTED

DEADLINE

Rapid DNA Testing ServicesThe contract seeks a subcontractor to provide Rapid DNA collection and analysis services that meet AABB accreditation standards, with the explicit requirement that results not be uploaded to CODIS. This service is intended to deliver timely, accurate, and accredited DNA testing in settings where federal DNA database inclusion is prohibited, ensuring compliance with both technical and regulatory protocols. The provider must demonstrate the ability to perform end-to-end DNA processing—from sample collection through analysis—with verified adherence to quality assurance benchmarks aligned with AABB guidelines. The solicitation is classified as a subcontract under the NAICS code 621511 and is managed by the Omas Strategic Buying Center under the Department of Health and Human Services. The opportunity was posted on August 2, 2026, with responses due by August 10, 2026. While specific performance locations and point of contact details are not provided, the work is anticipated to support federal or partner operations requiring rapid DNA results without federal database integration. Bidders must be prepared to meet stringent quality controls, maintain full documentation of processes, and ensure seamless integration into existing workflows without leveraging CODIS infrastructure.

Omas Strategic Buying Center - HHS Mission

POSTED

DEADLINE

Medical Laboratory Testing – MRD Analysis via clonoSEQ AssayThe contract calls for the performance of 100 annual Measurable Residual Disease tests using the proprietary clonoSEQ assay for Veterans diagnosed with hematologic malignancies. Each test must be conducted using an FDA-cleared and CLIA-validated methodology to ensure clinical accuracy and regulatory compliance. The work is structured as a subcontract under the Department of Veterans Affairs, specifically managed by the 244-NETWORK Contract Office 4, and falls under the NAICS code 621511 for medical laboratory services. The solicitation was posted on July 31, 2026, with a response deadline of August 10, 2026, indicating a tight procurement timeline. While the place of performance and point of contact details are not specified, the requirement emphasizes standardized, validated laboratory testing to support clinical decision-making for Veterans, with no set-aside provisions identified.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Q301--Lab Testing Services - clonoSEQ Measurable Residual Disease Test Pittsburgh VA Medical Center - Pittsburgh, PA

Solicitation # 36C24426Q0855

The Department of Veterans Affairs’ Network Contracting Office 4 intends to award a sole source contract to Adaptive Biotechnologies Corporation for the provision of clonoSEQ Measurable Residual Disease (MRD) testing services at the Pittsburgh VA Medical Center. This action is justified under FAR 6.103-1 because Adaptive Biotechnologies is the exclusive provider of the clonoSEQ assay, a proprietary, FDA-cleared, and CLIA-validated molecular test used to detect MRD in patients with multiple myeloma, B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and other lymphoid malignancies. The contract will use simplified acquisition procedures, be firm fixed price, and span a five-year period with an annual quantity of 100 tests. The solicitation number is 36C24426Q0855, and the NAICS code is 621511 with a size standard of $41.5 million. Any interested party may submit a capability statement prior to the response deadline of August 10, 2026, at 8:00 AM Eastern Standard Time, but the Government retains full discretion to proceed without competition based on the unique nature of the technology and the absence of viable alternatives. Responses must include the company name, SAM UEI number, address, point of contact details, business size, and evidence demonstrating the ability to perform the service, including relevant experience, contract numbers, dollar amounts, performance periods, and customer contacts. All submissions must be emailed to Mickeya Linzie at mickeya.linzie@va.gov and must clearly state whether the respondent is the direct provider or an authorized reseller. No submissions will be accepted after the deadline, and all information provided becomes the property of the Government.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Drug and Alcohol Testing ServicesThe contract requires the provision of drug and alcohol testing services for construction personnel in alignment with SAMHSA guidelines, ensuring compliance with federal standards for workplace safety. Testing must include EMIT screening as an initial method followed by definitive GC/MS confirmation to ensure accurate and legally defensible results. The scope of work is specifically targeted at personnel involved in construction activities under the purview of the Professional Services Department of the Los Angeles Community College District, with all testing protocols required to meet the highest regulatory benchmarks for accuracy, chain of custody, and reporting. The solicitation is classified as a subcontract with a response deadline of September 1, 2026, and is associated with NAICS code 621511, indicating clinical laboratory services. The place of performance and agency location are not precisely defined in the data, but the contracting entity operates within California. There is no set-aside designation specified, meaning the contract is open to all eligible vendors. The official posting is accessible via the provided vendor portal link, and prospective bidders must ensure full adherence to SAMHSA compliance requirements, laboratory accreditation standards, and timely submission of proposed services and pricing by the stated deadline.

Professional Services Department of Los Angeles Community College District

POSTED

DEADLINE

Newborn Screening Laboratory Testing ServicesThis contract is for the provision of newborn screening laboratory testing services required by state mandates, encompassing first, second, and repeat screenings for metabolic, genetic, and congenital disorders using specialized diagnostic assays. The work involves highly precise laboratory procedures to detect rare but serious conditions in newborns, ensuring early intervention and improved health outcomes. All testing must meet stringent quality and regulatory standards to guarantee accuracy and timeliness, with results delivered promptly to healthcare providers. The contract is a subcontract advertised by the Navajo Area Indian Health Service under the U.S. Department of Health and Human Services, with performance expected to occur in the 86503 zip code area. It falls under NAICS code 621511 for medical and diagnostic laboratories and has a response deadline of August 14, 2026. The solicitation does not specify a set-aside type or point of contact, and the location details for the agency’s office are incomplete, but the place of performance is clearly defined to ensure services are delivered within the designated service region.

Navajo Area Indian Health Svc

POSTED

DEADLINE

Clinical Pathology and Chemistry AnalysisThe contract involves performing comprehensive hematological and biochemical analysis on blood and bodily fluids to evaluate organ function, hydration levels, infection markers, and metabolic health, including standard tests such as complete blood counts and serum chemistry panels. This work is critical for clinical assessment and diagnostic support within a veterinary or wildlife health context, given the contracting agency’s association with the Department of the Interior. The opportunity is structured as a subcontract under NAICS code 621511, indicating it falls under medical and diagnostic laboratories, and is open for response until August 20, 2026, with a posting date of July 30, 2026. The place of performance and point of contact details are not specified, but the work is tied to Sat Team 2 Fws, suggesting operational coordination with federal wildlife or conservation programs.

POSTED

DEADLINE

Fecal Parasite Screening and Ova/Cyst DetectionThe contract requires the analysis of fecal samples to detect parasitic organisms, specifically *Cryptosporidium* and *Giardia*, through standardized laboratory techniques including flotation, staining, and microscopic examination. The provider must identify the presence of these parasites, quantify their levels, and provide precise morphological characterization in the final reporting. All work must adhere to accepted protocols for accurate and reproducible results, ensuring reliable data for health and environmental assessments. The services are anticipated to support monitoring and regulatory efforts related to waterborne and zoonotic pathogens. This is a subcontract under the Department of the Interior's Sat Team 2 Fws, with a North American Industry Classification System code of 621511 indicating diagnostic services. The solicitation was posted on July 30, 2026, and responses must be submitted by August 20, 2026. No specific location is designated for performance, and no set-aside criteria are specified. The work is expected to be conducted under laboratory conditions with appropriate biosafety measures, and deliverables must include detailed reports outlining findings for each sample analyzed.

POSTED

DEADLINE

Bacterial Culture and Antimicrobial Susceptibility TestingThe contract requires the isolation and identification of bacteria from clinical specimens using standardized microbiological techniques, including both aerobic and anaerobic culturing methods to ensure comprehensive pathogen detection. It further mandates the performance of antimicrobial susceptibility testing to determine bacterial resistance profiles, providing critical data to inform clinical treatment decisions. The work must be conducted with precision and adherence to current laboratory standards to support accurate diagnostic and therapeutic outcomes. This subcontract is issued under the NAICS code 621511, reflecting its alignment with medical and diagnostic laboratory services, and is managed by the Department of the Interior through its Sat Team 2 Fws entity. The solicitation was posted on July 30, 2026, with a firm deadline for responses set for August 20, 2026. The place of performance and contact details are unspecified, but the work is expected to be carried out in a clinical laboratory setting capable of handling infectious specimens and conducting advanced microbiological analyses under appropriate biosafety conditions.

POSTED

DEADLINE